selected publications
- Erratum: International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma. 2025 GET IT
 - Deeper response predicts better outcomes in high-risk-smoldering-myeloma: results of the I-PRISM phase II clinical trial. Nature communications. 2025 Academic Article GET IT
 -     
    
    
                     Absolute lymphocyte count after BCMA CAR-T therapy is a predictor of response and outcomes in relapsed multiple myeloma. 
 
                    Blood advances. 
            
             2024
             
			
			
			
			
			
			Academic Article
 			GET IT
 			
Times cited: 10 - Long-Term Follow-Up Defines the Population That Benefits from Early Interception in a High-Risk Smoldering Multiple Myeloma Clinical Trial Using the Combination of Ixazomib, Lenalidomide, and Dexamethasone. 2024 GET IT
 -     
    
    
                     Biomarkers of Progression and Risk Stratification in Asymptomatic Waldenström Macroglobulinemia. 
 
                    Hematology/oncology clinics of North America.
            
             2023
             
			
			
			
			
			
			Review
 			GET IT
 			
Times cited: 1 -     
    
    
                     Angioimmunoblastic T-cell lymphoma presenting with severe plasmacytosis mimicking plasma cell leukemia.
              2023
  			GET IT
 			
Times cited: 4 - Immune biomarkers of response to immunotherapy in patients with high-risk smoldering myeloma. Cancer cell. 2022 Academic Article GET IT
 -     
    
    
                     Advances in the molecular characterization of multiple myeloma and mechanism of therapeutic resistance. 
 
                    Frontiers in oncology.
            
             2022
             
			
			
			
			
			
			Review
 			GET IT
 			
Times cited: 9 - Genetic subtypes of smoldering multiple myeloma are associated with distinct pathogenic phenotypes and clinical outcomes. Nature communications. 2022 Academic Article GET IT
 - Prevalence of monoclonal gammopathies and clinical outcomes in a high-risk US population screened by mass spectrometry: a multicentre cohort study. The Lancet. Haematology. 2022 Academic Article GET IT
 - Regular Aspirin Use and Mortality in Multiple Myeloma Patients. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2021 Academic Article GET IT
 - An Overview of Selected Rare B-Cell Lymphoproliferative Disorders: Imaging, Histopathologic, and Clinical Features. Cancers. 2021 Review GET IT
 - Placental extracellular vesicles-associated microRNA-519c mediates endotoxin adaptation in pregnancy. American journal of obstetrics and gynecology. 2021 Academic Article GET IT
 -     
    
    
                     Pregnancy outcomes, risk factors, and cell count trends in pregnant women with essential thrombocythemia. 
 
                    Leukemia research. 
            
             2020
             
			
			
			
			
			
			Academic Article
 			GET IT
 			
Times cited: 5 -     
    
    
                     Genome instability in multiple myeloma. 
 
                    Leukemia.
            
             2020
             
			
			
			
			
			
			Information Resource
 			GET IT
 			
Times cited: 9 -     
    
    
                     Clonal hematopoiesis is associated with adverse outcomes in multiple myeloma patients undergoing transplant. 
 
                    Nature communications. 
            
             2020
             
			
			
			
			
			
			Academic Article
 			GET IT
 			
Times cited: 142 - Single-cell RNA sequencing reveals compromised immune microenvironment in precursor stages of multiple myeloma. Nature cancer. 2020 Academic Article GET IT
 -     
    
    
                     Genomic Landscape of Waldenström Macroglobulinemia and Its Impact on Treatment Strategies. 
 
                    Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
            
             2020
             
			
			
			
			
			
			Information Resource
 			GET IT
 			
Times cited: 140 -     
    
    
                     Bone marrow niche in multiple myeloma and its precursor states. 
 
                    HemaSphere. 
            
             2019
             
			
			
			
			
			
			Academic Article
 			GET IT
 			
Times cited: 3 -     
    
    
                     Progression Risk Stratification of Asymptomatic Waldenström Macroglobulinemia. 
 
                    Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 
            
             2019
             
			
			
			
			
			
			Academic Article
 			GET IT
 			
Times cited: 79 -     
    
    
                     Bone marrow biopsy in low-risk monoclonal gammopathy of undetermined significance reveals a novel smoldering multiple myeloma risk group. 
 
                    American journal of hematology. 
            
             2019
             
			
			
			
			
			
			Article
 			GET IT
 			
Times cited: 4 -     
    
    
                     Bortezomib overcomes the negative impact of CXCR4 mutations on survival of Waldenstrom macroglobulinemia patients. 
 
                    Blood. 
            
             2018
             
			
			
			
			
			
			Article
 			GET IT
 			
Times cited: 33 -     
    
    
                     Profiling of circulating exosomal miRNAs in patients with Waldenström Macroglobulinemia. 
 
                    PloS one. 
            
             2018
             
			
			
			
			
			
			Academic Article
 			GET IT
 			
Times cited: 20 -     
    
    
                     Advancements in Nanomedicine for Multiple Myeloma. 
 
                    Trends in molecular medicine.
            
             2018
             
			
			
			
			
			
			Information Resource
 			GET IT
 			
Times cited: 11 -     
    
    
                     Blocking IFNAR1 inhibits multiple myeloma-driven Treg expansion and immunosuppression. 
 
                    The Journal of clinical investigation. 
            
             2018
             
			
			
			
			
			
			Academic Article
 			GET IT
 			
Times cited: 92 -     
    
    
                     Whole-exome sequencing of cell-free DNA and circulating tumor cells in multiple myeloma. 
 
                    Nature communications. 
            
             2018
             
			
			
			
			
			
			Academic Article
 			GET IT
 			
Times cited: 167 -     
    
    
                     A Rare Case of Composite Dural Extranodal Marginal Zone Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. 
 
                    Frontiers in neurology.
            
             2018
             
			
			
			
			
			
			Information Resource
 			GET IT
 			
Times cited: 19 -     
    
    
                     Established and Novel Prognostic Biomarkers in Multiple Myeloma. 
 
                    American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.
            
             2017
             
			
			
			
			
			
			Information Resource
 			GET IT
 			
Times cited: 18 -     
    
    
                     Patient-Specific Screening Using High-Grade Glioma Explants to Determine Potential Radiosensitization by a TGF-β Small Molecule Inhibitor. 
 
                    Neoplasia (New York, N.Y.). 
            
             2016
             
			
			
			
			
			
			Academic Article
 			GET IT
 			
Times cited: 34 -     
    
    
                     Traumatic brain injury and subsequent glioblastoma development: Review of the literature and case reports. 
 
                    Surgical neurology international. 
            
             2016
             
			
			
			
			
			
			Academic Article
 			GET IT
 			
Times cited: 30 - Adult Primary Spinal Epidural Extraosseous Ewing's Sarcoma: A Case Report and Review of the Literature. Case reports in neurological medicine. 2016 Academic Article GET IT